Form 4: Bausch + Lomb Director Boosts Stake with Share Purchase

Bausch + Lomb Corporation Director Thomas W. Ross Sr. acquired 4,500 common shares and received 4,500 matching restricted share units.

Summary

• Director Thomas W. Ross Sr. purchased 4,500 common shares of Bausch + Lomb Corporation (BLCO) on March 3, 2026.
• The shares were acquired at a weighted average price of $17.679, with individual transaction prices ranging from $17.672 to $17.690.
• In connection with this open market purchase, Mr. Ross Sr. was granted 4,500 matching restricted share units (MRSUs).
• These MRSUs will vest in three equal annual installments, one-third on each of the first, second, and third anniversaries of the grant date, contingent on his continued service.
• Following these transactions, Mr. Ross Sr. beneficially owns a total of 69,391 common shares directly.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, as insider buying demonstrates confidence in the company's future, further strengthened by the long-term incentive of matching restricted share units.

Positives

• A director's open market purchase of shares indicates confidence in the company's future prospects.
• The grant of matching restricted share units aligns the director's long-term interests with those of shareholders through a multi-year vesting schedule.

Future Outlook

The vesting schedule for the matching restricted share units indicates a commitment to the company's performance over the next three years, contingent on the director's continued service.

Industry Context

StockSavvy.ai notes that insider buying, particularly by a director, often signals management's belief in the company's undervalued stock or strong future prospects, which can be a positive indicator for investors in the healthcare and vision care industry. This action aligns the director's financial interests with long-term shareholder value, a common practice in corporate governance.

Comparison to Industry Standards

• StockSavvy.ai observes that insider purchases, especially when coupled with performance-based equity grants like MRSUs, are a standard mechanism to align executive and director incentives with shareholder returns.
• Similar practices are seen in companies like Alcon (ALC) or CooperCompanies (COO), where executive stock ownership and long-term incentive plans are common.
• The specific volume of shares purchased and granted is relative to the director's overall compensation and the company's market capitalization, but the underlying principle of aligning interests is consistent with industry best practices.

Corporate Governance

Related Party Transactions

• Director Thomas W. Ross Sr. purchased 4,500 common shares from the open market.
• Director Thomas W. Ross Sr. received 4,500 matching restricted share units from the issuer.

Stakeholder Impact

• Shareholders: Potentially positive, as insider buying can signal confidence and the MRSUs align director interests with long-term shareholder value.

Next Steps

• One-third of the matching restricted share units will vest on March 3, 2027.
• Another one-third of the matching restricted share units will vest on March 3, 2028.
• The final one-third of the matching restricted share units will vest on March 3, 2029.

Key Dates

Recommendation

The director's open market purchase, combined with the grant of matching restricted share units, signals strong insider confidence in Bausch + Lomb's future performance and valuation. This alignment of interests, particularly from a director, suggests a favorable outlook for the stock, warranting a 'buy' recommendation for seasoned investors.

Keywords

Bausch + Lomb, BLCO, Insider Buying, Director Share Purchase, Restricted Share Units, Executive Compensation, SEC Form 4, Beneficial Ownership